In an AMPK-dependent pathway, metformin promotes small heterodimer partner (SHP) protein production and ameliorates hepatic insulin resistance by regulating gluconeogenesis and insulin sensitivity [28]. The gene discussed is INS; the disease is Insulin resistance.